EOLS Stock Summary and Trading Ideas (Evolus | NASDAQ:EOLS)

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Evolus trades on the NASDAQ stock market under the symbol EOLS.

As of February 26, 2026, EOLS stock price climbed to $4.54 with 44,544 million shares trading.

EOLS has a beta of 0.36, meaning it tends to be less sensitive to market movements. EOLS has a correlation of 0.01 to the broad based SPY ETF.

EOLS has a market cap of $294.28 million. This is considered a Small Cap stock.

Last quarter Evolus reported $69 million in Revenue and -$.11 earnings per share. This beat revenue expectation by $1 million and exceeded earnings estimates by $.10.

In the last 3 years, EOLS traded as high as $17.82 and as low as $4.09.

The top ETF exchange traded funds that EOLS belongs to (by Net Assets): VTI, IWM, VXF, XPH, IWO.

EOLS has underperformed the market in the last year with a return of -67.5%, while the SPY ETF gained +16.9%. In the last 3 month period, EOLS fell short of the market, returning -35.0%, while SPY returned +2.1%. However, in the most recent 2 weeks EOLS has outperformed the stock market by returning +5.6%, while SPY returned -0.6%.

EOLS support price is $4.35 and resistance is $4.65 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EOLS shares will trade within this expected range on the day.